Clinical trial
An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder
NCT00330655 · Mclean Hospital, Other · Completed
Key facts
| NCT number | NCT00330655 |
|---|---|
| Title | An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder |
| Official title | An Open-Label, Prospective Trial of Memantine in the Treatment of Moderate to Severe Binge Eating Disorder Associated With Obesity |
| Lead sponsor | Mclean Hospital, Other |
| Collaborators | Forest Laboratories Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Binge Eating Disorder |
| Intervention type | Drug |
| Interventions | memantine |
| Enrollment | 15 |
| Start date | May 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | May 29, 2006 |
| Last update posted | Aug 14, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: